TNFRSF1A and glioblastoma: Thus, inhibition of cytotoxic ligands/mediators revealed that two main pathways underlie cytotoxic activity of donor IFN-DCs against most glioblastoma cells, i.e., granule-dependent and TNFα/TNF-R1-dependent pathways.